Metacrine, Inc.
MTCRDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634379
Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Metacrine, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 47 | 42 | −5 |
| Shares | 13.2M | 12.5M | −768.5K (−5.8%) |
| Value | $82.1M | $47.4M | −$34.7M (−42.3%) |
New holders (8)
Institutions that held Metacrine, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 79,900 | $304.0K | 0.00% |
| Two Sigma Investments, LP | 64,823 | $246.0K | 0.00% |
| Ergoteles LLC | 29,900 | $114.0K | 0.00% |
| Virtu Financial LLC | 19,671 | $75.0K | 0.01% |
| Wedbush Securities Inc | 12,700 | $48.0K | 0.00% |
| Citadel Advisors LLC | 12,710 | $48.0K | 0.00% |
| Walleye Capital LLC | 11,787 | $45.0K | 0.00% |
| Fifth Third Bancorp | 900 | $3.00K | 0.00% |
Sold out (13)
Institutions that held Metacrine, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| VR Adviser, LLC | 680,000 | $4.22M |
| Alyeska Investment Group, L.P. | 179,782 | $1.11M |
| EcoR1 Capital, LLC | 62,207 | $386.0K |
| Charles Schwab Investment Management Inc | 13,800 | $86.0K |
| Bank of New York Mellon Corp | 11,090 | $69.0K |
| Nuveen Asset Management, LLC | 10,906 | $68.0K |
| California State Teachers Retirement System | 9,999 | $62.0K |
| Deutsche Bank AG | 4,242 | $26.0K |
| American International Group, Inc. | 3,853 | $24.0K |
| STRS Ohio | 1,600 | $9.00K |
| Legal & General Group Plc | 527 | $3.00K |
| Ameritas Investment Partners, Inc. | 555 | $3.00K |
| Bank of Montreal | 233 | $1.00K |